Spark Biopharma
Seoul
About Spark Biopharma
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $23.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2022)
- Website: sparkbio.kr
- Phone: +82-2-887-9090
Industries & Categories
Biotechnology, Chemical, Health Care, Medical
Canonical: https://fsome.com/organization/spark-biopharma-8822 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.